Filing Details
- Accession Number:
- 0001104659-23-036172
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-23 20:28:29
- Reporting Period:
- 2023-03-23
- Accepted Time:
- 2023-03-23 20:28:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326190 | Altimmune Inc. | ALT | Pharmaceutical Preparations (2834) | 202726770 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1787762 | Scott Matthew Harris | C/O Altimmune, Inc., 910 Clopper Road, Suite 201S Gaithersburg MD 20878 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 | Acquisiton | 2023-03-23 | 10,000 | $4.22 | 33,311 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
